Clinical trial
Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes
NCT05205005 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes
- Lead sponsor
- VA Office of Research and Development
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 25, 2022
- Completion date
- July 31, 2024
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.